Combo Product Firms Lose Patience As Regs, Guidance Are Delayed Again
This article was originally published in The Gray Sheet
Executive Summary
Combination product companies want the next FDA commissioner to raise the profile of combo product issues within the agency
You may also be interested in...
Combination Product Rules Clear OMB, To Be Released In Weeks
Two key proposed rules from FDA's Office of Combination Products have finally received Office of Management and Budget approval and should be out for comment in the coming weeks, according to OCP Director Thinh Nguyen
Combination Product Rules Clear OMB, To Be Released In Weeks
Two key proposed rules from FDA's Office of Combination Products have finally received Office of Management and Budget approval and should be out for comment in the coming weeks, according to OCP Director Thinh Nguyen
Combination Product Rules Clear OMB, To Be Released In Weeks
FDA's general idea is for companies to choose one operating system, drug or device, then tack on procedures certain components require, not follow different rules for different components, agency expert says at RAPS.